vs

Side-by-side financial comparison of INNSUITES HOSPITALITY TRUST (IHT) and Insight Molecular Diagnostics Inc. (IMDX). Click either name above to swap in a different company.

INNSUITES HOSPITALITY TRUST is the larger business by last-quarter revenue ($1.8M vs $1.1M, roughly 1.6× Insight Molecular Diagnostics Inc.). INNSUITES HOSPITALITY TRUST runs the higher net margin — -19.8% vs -2015.4%, a 1995.6% gap on every dollar of revenue. On growth, INNSUITES HOSPITALITY TRUST posted the faster year-over-year revenue change (-1.1% vs -23.4%). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 2.1%).

InnSuites Hospitality Trust, based in Phoenix, Arizona, is a real estate investment trust that invests in lodging. While it is formed as a real estate investment trust, it is not classified as a real estate investment trust for tax purposes. The company owns interests in two hotels, operates three hotels, provides management for three hotels, and licenses its InnSuites trademark for five hotels. The company's hotel ownership interests are a 51.01% interest in the Best Western InnSuites Tucson...

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

IHT vs IMDX — Head-to-Head

Bigger by revenue
IHT
IHT
1.6× larger
IHT
$1.8M
$1.1M
IMDX
Growing faster (revenue YoY)
IHT
IHT
+22.3% gap
IHT
-1.1%
-23.4%
IMDX
Higher net margin
IHT
IHT
1995.6% more per $
IHT
-19.8%
-2015.4%
IMDX
Faster 2-yr revenue CAGR
IMDX
IMDX
Annualised
IMDX
154.4%
2.1%
IHT

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
IHT
IHT
IMDX
IMDX
Revenue
$1.8M
$1.1M
Net Profit
$-356.9K
$-23.0M
Gross Margin
42.5%
Operating Margin
-10.0%
-2057.5%
Net Margin
-19.8%
-2015.4%
Revenue YoY
-1.1%
-23.4%
Net Profit YoY
-29.1%
31.5%
EPS (diluted)
$-0.04
$-0.75

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IHT
IHT
IMDX
IMDX
Q4 25
$1.8M
$1.1M
Q3 25
$1.8M
$260.0K
Q2 25
$2.2M
$518.0K
Q1 25
$1.6M
$2.1M
Q4 24
$1.8M
$1.5M
Q3 24
$1.8M
$115.0K
Q2 24
$7.5M
$104.0K
Q1 24
$1.7M
$176.0K
Net Profit
IHT
IHT
IMDX
IMDX
Q4 25
$-356.9K
$-23.0M
Q3 25
$-391.2K
$-10.9M
Q2 25
$-121.0K
$-9.7M
Q1 25
$-595.2K
$-6.7M
Q4 24
$-276.4K
$-33.5M
Q3 24
$-370.9K
$-13.5M
Q2 24
$-148.6K
$-4.5M
Q1 24
$-113.0K
$-9.1M
Gross Margin
IHT
IHT
IMDX
IMDX
Q4 25
42.5%
Q3 25
53.5%
Q2 25
67.6%
Q1 25
62.0%
Q4 24
40.0%
Q3 24
43.5%
Q2 24
48.1%
Q1 24
25.6%
Operating Margin
IHT
IHT
IMDX
IMDX
Q4 25
-10.0%
-2057.5%
Q3 25
-13.3%
-4249.2%
Q2 25
10.1%
-1900.0%
Q1 25
-30.9%
-318.0%
Q4 24
-7.1%
-2262.9%
Q3 24
-15.5%
-11752.2%
Q2 24
2.4%
-4453.8%
Q1 24
-35.3%
-5265.3%
Net Margin
IHT
IHT
IMDX
IMDX
Q4 25
-19.8%
-2015.4%
Q3 25
-21.7%
-4174.6%
Q2 25
-5.5%
-1880.7%
Q1 25
-36.4%
-312.0%
Q4 24
-15.1%
-2255.1%
Q3 24
-20.2%
-11733.0%
Q2 24
-2.0%
-4355.8%
Q1 24
-6.5%
-5186.9%
EPS (diluted)
IHT
IHT
IMDX
IMDX
Q4 25
$-0.04
$-0.75
Q3 25
$-0.04
$-0.34
Q2 25
$-0.01
$-0.30
Q1 25
$-0.07
$-0.26
Q4 24
$-0.03
$-2.19
Q3 24
$-0.04
$-0.98
Q2 24
$-0.02
$-0.36
Q1 24
$-0.02
$-1.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IHT
IHT
IMDX
IMDX
Cash + ST InvestmentsLiquidity on hand
$11.6M
Total DebtLower is stronger
$11.3M
Stockholders' EquityBook value
$3.6M
$-31.5M
Total Assets
$13.9M
$25.8M
Debt / EquityLower = less leverage
3.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IHT
IHT
IMDX
IMDX
Q4 25
$11.6M
Q3 25
$18.7M
Q2 25
$24.3M
Q1 25
$31.0M
Q4 24
$8.6M
Q3 24
$3.4M
Q2 24
$9.3M
Q1 24
$1.3M
$5.6M
Total Debt
IHT
IHT
IMDX
IMDX
Q4 25
$11.3M
Q3 25
$11.2M
Q2 25
$10.5M
Q1 25
$10.7M
Q4 24
$10.3M
Q3 24
$10.0M
Q2 24
$9.7M
Q1 24
$9.7M
Stockholders' Equity
IHT
IHT
IMDX
IMDX
Q4 25
$3.6M
$-31.5M
Q3 25
$4.0M
$-9.2M
Q2 25
$4.4M
$1.1M
Q1 25
$4.6M
$10.2M
Q4 24
$5.2M
$-12.3M
Q3 24
$5.5M
$9.7M
Q2 24
$6.0M
$22.7M
Q1 24
$6.2M
$11.6M
Total Assets
IHT
IHT
IMDX
IMDX
Q4 25
$13.9M
$25.8M
Q3 25
$14.2M
$43.9M
Q2 25
$14.0M
$50.5M
Q1 25
$14.2M
$60.4M
Q4 24
$15.0M
$35.1M
Q3 24
$15.1M
$70.2M
Q2 24
$15.3M
$74.7M
Q1 24
$15.7M
$71.0M
Debt / Equity
IHT
IHT
IMDX
IMDX
Q4 25
3.12×
Q3 25
2.82×
Q2 25
2.37×
Q1 25
2.34×
Q4 24
1.98×
Q3 24
1.81×
Q2 24
1.61×
Q1 24
1.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IHT
IHT
IMDX
IMDX
Operating Cash FlowLast quarter
$-145.1K
$-5.5M
Free Cash FlowOCF − Capex
$-7.0M
FCF MarginFCF / Revenue
-616.7%
Capex IntensityCapex / Revenue
129.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-25.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IHT
IHT
IMDX
IMDX
Q4 25
$-145.1K
$-5.5M
Q3 25
$-153.0K
$-4.5M
Q2 25
$279.8K
$-6.3M
Q1 25
$-1.1M
$-5.9M
Q4 24
$-146.7K
$-5.4M
Q3 24
$-44.6K
$-5.5M
Q2 24
$-459.4K
$-6.0M
Q1 24
$1.4M
$-3.8M
Free Cash Flow
IHT
IHT
IMDX
IMDX
Q4 25
$-7.0M
Q3 25
$-5.6M
Q2 25
$-6.6M
Q1 25
$-6.2M
Q4 24
$-5.6M
Q3 24
$-5.6M
Q2 24
$-6.2M
Q1 24
$-3.9M
FCF Margin
IHT
IHT
IMDX
IMDX
Q4 25
-616.7%
Q3 25
-2135.4%
Q2 25
-1279.5%
Q1 25
-288.4%
Q4 24
-374.5%
Q3 24
-4884.3%
Q2 24
-5931.7%
Q1 24
-2189.8%
Capex Intensity
IHT
IHT
IMDX
IMDX
Q4 25
129.9%
Q3 25
403.8%
Q2 25
67.4%
Q1 25
14.4%
Q4 24
14.4%
Q3 24
75.7%
Q2 24
183.7%
Q1 24
13.6%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IHT
IHT

Room$1.7M96%
Other$74.1K4%

IMDX
IMDX

Segment breakdown not available.

Related Comparisons